STING Agonist Mitigates Experimental Autoimmune Encephalomyelitis by Stimulating Type I IFN-Dependent and -Independent Immune-Regulatory Pathways.
STING Agonist Mitigates Experimental Autoimmune Encephalomyelitis by Stimulating Type I IFN-Dependent and -Independent Immune-Regulatory Pathways.
复制标题
DOI:
10.4049/jimmunol.2001317
复制
发表时间:
2021-05-01
期刊:
影响因子:
--
通讯作者:
Ting JP
中科院分区:
文献类型:
--
作者:
Johnson BM;Uchimura T;Gallovic MD;Thamilarasan M;Chou WC;Gibson SA;Deng M;Tam JW;Batty CJ;Williams J;Matsushima GK;Bachelder EM;Ainslie KM;Markovic-Plese S;Ting JP
The cGAS–cyclic GMP–AMP (cGAMP)–stimulator of IFN genes (STING) pathway induces a powerful type I IFN (IFN-I) response and is a prime candidate for augmenting immunity in cancer immunotherapy and vaccines. IFN-I also has immune-regulatory functions manifested in several autoimmune diseases and is a first-line therapy for relapsing–remitting multiple sclerosis. However, it is only moderately effective and can induce adverse effects and neutralizing Abs in recipients. Targeting cGAMP in autoimmunity is unexplored and represents a challenge because of the intracellular location of its receptor, STING. We used microparticle (MP)–encapsulated cGAMP to increase cellular delivery, achieve dose sparing, and reduce potential toxicity. In the C57BL/6 experimental allergic encephalomyelitis (EAE) model, cGAMP encapsulated in MPs (cGAMP MPs) administered therapeutically protected mice from EAE in a STING-dependent fashion, whereas soluble cGAMP was ineffective. Protection was also observed in a relapsing–remitting model. Importantly, cGAMP MPs protected against EAE at the peak of disease and were more effective than rIFN-β. Mechanistically, cGAMP MPs showed both IFN-I–dependent and –independent immunosuppressive effects. Furthermore, it induced the immunosuppressive cytokine IL-27 without requiring IFN-I. This augmented IL-10 expression through activated ERK and CREB. IL-27 and subsequent IL-10 were the most important cytokines to mitigate autoreactivity. Critically, cGAMP MPs promoted IFN-I as well as the immunoregulatory cytokines IL-27 and IL-10 in PBMCs from relapsing–remitting multiple sclerosis patients. Collectively, this study reveals a previously unappreciated immune-regulatory effect of cGAMP that can be harnessed to restrain T cell autoreactivity.
登录
查看更多内容
DOI:
10.1073/pnas.1512832112
发表时间:
2015-12-15
影响因子:
11.1
作者:
Demaria, Olivier;De Gassart, Aude;Gilliet, Michel
通讯作者:
Gilliet, Michel
影响因子:
8.8
作者:
Ahn J;Son S;Oliveira SC;Barber GN
通讯作者:
Barber GN
DOI:
10.1016/j.bbadis.2015.08.011
发表时间:
2015-11-01
影响因子:
6.2
作者:
Ding, Liang;Huang, Xiao-Feng;Hou, Ya-Yi
通讯作者:
Hou, Ya-Yi
DOI:
10.1073/pnas.1215006109
发表时间:
2012-11-20
影响因子:
11.1
作者:
Ahn, Jeonghyun;Gutman, Delia;Barber, Glen N.
通讯作者:
Barber, Glen N.
影响因子:
7.7
作者:
Blaauboer SM;Mansouri S;Tucker HR;Wang HL;Gabrielle VD;Jin L
通讯作者:
Jin L